Commission Implementing Regulation (EU) 2026/2348 of 23 October 2026 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances 2,5-dichlorobenzoic acid methylester, acequinocyl, acetic acid, aluminium phosphide, amidosulfuron, buprofezin, calcium carbide, emamectin, ethylene, fatty acids C7 to C20, fenoxaprop-P, flonicamid (IKI-220), halosulfuron-methyl, iron sulphate, magnesium phosphide, metamitron, orange oil, quinmerac, sodium